Effect of Saffron Supplementation on Macular Cone-mediated Function in Age-related Macular Degeneration
safAMD
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a pilot interventional study whose aim is to determine the effect of a dietary supplementation with a Crocus Sativus extract, Saffron, on macular cone-mediated function in patients with early age-related macular degeneration (AMD). Pre-clinical evidence ( Maccarone R, Di Marco S, Bisti S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1254-61.) indicates the potential effectiveness of Saffron as a retinal neuroprotectant in animal models of retinal degenerative disorders.The macular function will be tested by visual acuity and macular cone-mediated electroretinogram (focal electroretinogram, FERG) according to a standardized technique (see citations).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jun 2009
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 3, 2009
CompletedFirst Posted
Study publicly available on registry
August 4, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedAugust 3, 2015
July 1, 2015
6.4 years
August 3, 2009
July 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Focal Electroretinogram Amplitude and Phase
6 months
Secondary Outcomes (1)
Visual Acuity
6 months
Study Arms (2)
Saffron
ACTIVE COMPARATORCrocus Sativus extract
Placebo
PLACEBO COMPARATORPlacebo comparator
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 55 yrs
- Diagnosis of Early, non exudative AMD
- Visual acuity of 20/40 or better
You may not qualify if:
- Concomitant ocular or systemic disorders which may affect macular function
- Drugs that may affect macular function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Policlinico A. Gemelli, Institute of Ophthalmology
Rome, 00168, Italy
Related Publications (4)
Maccarone R, Di Marco S, Bisti S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1254-61. doi: 10.1167/iovs.07-0438.
PMID: 18326756BACKGROUNDFalsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology. 2003 Jan;110(1):51-60; discussion 61. doi: 10.1016/s0161-6420(02)01547-6.
PMID: 12511345BACKGROUNDFalsini B, Fadda A, Iarossi G, Piccardi M, Canu D, Minnella A, Serrao S, Scullica L. Retinal sensitivity to flicker modulation: reduced by early age-related maculopathy. Invest Ophthalmol Vis Sci. 2000 May;41(6):1498-506.
PMID: 10798669BACKGROUNDFalsini B, Piccardi M, Minnella A, Savastano C, Capoluongo E, Fadda A, Balestrazzi E, Maccarone R, Bisti S. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6118-24. doi: 10.1167/iovs.09-4995. Epub 2010 Aug 4.
PMID: 20688744RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benedetto Falsini, M.D.
Catholic University, Italy
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Ophthalmology
Study Record Dates
First Submitted
August 3, 2009
First Posted
August 4, 2009
Study Start
June 1, 2009
Primary Completion
November 1, 2015
Study Completion
December 1, 2015
Last Updated
August 3, 2015
Record last verified: 2015-07